title: Bendamustine-containing immunochemotherapy is active in transformed follicular lymphoma with overexpression of p53.
authors.affiliation: Department of Hematology, Hospital del Mar, Barcelona, Spain. 97894@imas.imim.es
authors.forename: Blanca
authors.initials: B
authors.lastname: Sanchez-Gonzalez
authors.forename: Mar
authors.initials: M
authors.lastname: Garcia
authors.forename: Sergi
authors.initials: S
authors.lastname: Serrano
authors.forename: Carles
authors.initials: C
authors.lastname: Besses
authors.forename: Antonio
authors.initials: A
authors.lastname: Salar
mesh_terms: D000368:Aged; D000069461:Bendamustine Hydrochloride; D005260:Female; D006801:Humans; D008224:Lymphoma, Follicular / Q000628:therapy*; D009588:Nitrogen Mustard Compounds / Q000627:therapeutic use*; D012008:Recurrence; D012074:Remission Induction; D016159:Tumor Suppressor Protein p53 / Q000235:genetics*
chemical_list: D009588:Nitrogen Mustard Compounds; D016159:Tumor Suppressor Protein p53; D000069461:Bendamustine Hydrochloride